牛叉诊股

同花顺高级诊股公告

同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！

同花顺特色产品: 〈高级诊股〉 全方位深度分析，提供明确投资建议

甘李药业（603087）

5.2

综合诊断：5.2分打败了29%的股票！

卖出
减持
中性
增持
买入

短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
中期趋势：
上涨趋势有所减缓，可适量高抛低吸。
长期趋势：
已有439家主力机构披露2025-06-30报告期持股数据，持仓量总计9871.36万股，占流通A股17.82%
波段诊断：
-
历史波段诊断>>

高级诊股策略资深顾问建议

分享到：

加自选 向专家提问

技术面诊股资金面诊股消息面诊股行业面诊股基本面诊股

4.6分

4.7分

5.5分

3.6分

6.7分

风险提示：诊断结果通过运算模型加工客观数据而成，仅供参考，不构成绝对投资建议。

技术面诊股

诊断结果：4.6技术面打败了11%的股票技术面评分前10的股票

近期的平均成本为65.84元。多头行情中，上涨趋势有所减缓，可适量做高抛低吸。

技术面得分最高的股票

平均成本

近期的平均成本为65.84元。

[{"text":"\u5e73\u5747\u6210\u672c","value":"65.84","date":1763284482,"color":"0x9f0ba1"}]

市场表现

过去10个交易日，该股走势明显跑输大盘，明显跑输行业平均水平。

[{"date":"2025.11.17","stock":"-2.38","trade":"-2.18","ind":"-0.46"},{"date":"2025.11.14","stock":"2.00","trade":"0.63","ind":"-0.97"},{"date":"2025.11.13","stock":"0.56","trade":"1.09","ind":"0.73"},{"date":"2025.11.12","stock":"2.26","trade":"0.87","ind":"-0.07"},{"date":"2025.11.11","stock":"-0.76","trade":"0.43","ind":"-0.39"},{"date":"2025.11.10","stock":"0.84","trade":"1.72","ind":"0.53"},{"date":"2025.11.07","stock":"-1.36","trade":"-0.48","ind":"-0.25"},{"date":"2025.11.06","stock":"1.18","trade":"-0.33","ind":"0.97"},{"date":"2025.11.05","stock":"-0.31","trade":"-0.81","ind":"0.23"},{"date":"2025.11.04","stock":"-3.62","trade":"-0.81","ind":"-0.41"},{"date":"2025.11.03","stock":"-1.74","trade":"0.04","ind":"0.55"},{"date":"2025.10.31","stock":"-2.75","trade":"4.09","ind":"-0.81"},{"date":"2025.10.30","stock":"-2.11","trade":"-0.83","ind":"-0.73"},{"date":"2025.10.29","stock":"1.08","trade":"1.00","ind":"0.70"},{"date":"2025.10.28","stock":"-1.22","trade":"0.24","ind":"-0.22"},{"date":"2025.10.27","stock":"3.91","trade":"0.61","ind":"1.18"},{"date":"2025.10.24","stock":"0.73","trade":"0.39","ind":"0.71"},{"date":"2025.10.23","stock":"-2.23","trade":"-1.29","ind":"0.22"},{"date":"2025.10.22","stock":"-1.41","trade":"-0.28","ind":"-0.07"},{"date":"2025.10.21","stock":"1.90","trade":"1.45","ind":"1.36"},{"date":"2025.10.20","stock":"0.27","trade":"0.44","ind":"0.63"}]

甘李药业,上证指数,生物制品指数

压力支撑

该股压力位为65.81元，支撑位为64.98元。

[{"text":"\u538b\u529b\u4f4d","value":"65.81","date":1763308800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"64.98","date":1763308800,"color":"0x0b52a1"}]

多空趋势

多头行情中，上涨趋势有所减缓，可适量做高抛低吸。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：4.7资金面打败了56%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力集中了一定的筹码，呈中度控盘状态。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

生物制品行业，近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。

更新时间：11月18日 08:20

机构今日流向(万元)	-3413.49	机构5日流向(万元)	-4843.79
机构10日流向(万元)	-10335.23	机构20日流向(万元)	-11100.01

机构持仓

2025-06-30 与 2024-12-31 相比，主力机构持仓量减少1825.99万股，其中基金净减仓59家，主力净增仓146家，暂未发现中长期投资价值。

截止2025-06-30，共439家主力机构（基金436家，一般法人2家，保险公司1家），持仓量总计9871.36万股，占流通A股17.82%
其中，基金持仓与2024-12-31相比：
增仓：74家，增持 401.76万股
减仓：133家，减持 656.80万股
新出现在主力名单中：215家，持有1235.52万股
从主力名单中消失：69家，原持有1998.58万股

消息面诊股

诊断结果：5.5消息面打败了68%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	重大事项	关联交易	2025-11-11
一般消息	股东大会	临时股东大会	2025-10-31
一般消息	分红转增	不分配不转增	2025-08-08
一般消息	募资投向		2025-08-08
重大利好	业绩预告	业绩大幅上升	2025-07-10
利好	分红转增	10派10元(含税)	2025-04-25
一般消息	重大事项	公司股东股份解押	2025-04-23
重大利好	业绩预告	业绩大幅上升	2025-01-21

一年消息统计

	所有消息	重大消息	非重大消息
利好	3条	2条	1条
利空	0条	0条	0条

行业面诊股

诊断结果：3.6行业面打败了45%的股票生物制品行业最新资金流向

近10日来该行业走势不明显，跑赢大盘。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，跑赢大盘。

[{"date":"2025.11.17","price":"-0.46","value":"-2.18"},{"date":"2025.11.14","price":"-0.97","value":"0.63"},{"date":"2025.11.13","price":"0.73","value":"1.09"},{"date":"2025.11.12","price":"-0.07","value":"0.87"},{"date":"2025.11.11","price":"-0.39","value":"0.43"},{"date":"2025.11.10","price":"0.53","value":"1.72"},{"date":"2025.11.07","price":"-0.25","value":"-0.48"},{"date":"2025.11.06","price":"0.97","value":"-0.33"},{"date":"2025.11.05","price":"0.23","value":"-0.81"},{"date":"2025.11.04","price":"-0.41","value":"-0.81"},{"date":"2025.11.03","price":"0.55","value":"0.04"},{"date":"2025.10.31","price":"-0.81","value":"4.09"},{"date":"2025.10.30","price":"-0.73","value":"-0.83"},{"date":"2025.10.29","price":"0.70","value":"1.00"},{"date":"2025.10.28","price":"-0.22","value":"0.24"},{"date":"2025.10.27","price":"1.18","value":"0.61"},{"date":"2025.10.24","price":"0.71","value":"0.39"},{"date":"2025.10.23","price":"0.22","value":"-1.29"},{"date":"2025.10.22","price":"-0.07","value":"-0.28"},{"date":"2025.10.21","price":"1.36","value":"1.45"},{"date":"2025.10.20","price":"0.63","value":"0.44"}]

上证指数,生物制品行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	金迪克	69.60%	25.18%	5.5分
2	博晖创新	42.35%	34.68%	5.8分
3	万泽股份	39.53%	-3.06%	6.7分
4	华兰疫苗	25.05%	-2.87%	6.0分
5	三生国健	21.51%	8.18%	5.8分
6	-	17.36%	1.67%	分
7	ST未名	11.24%	0.00%	5.8分
8	沃森生物	10.93%	0.80%	5.2分
9	康华生物	10.23%	4.60%	6.5分
10	近岸蛋白	9.32%	2.44%	5.1分
11	-	9.02%	-4.14%	分
12	优宁维	8.55%	3.40%	6.5分
13	-	8.05%	0.96%	分
14	*ST双成	7.75%	-0.98%	5.1分
15	赛升药业	7.72%	8.34%	5.9分
16	昊帆生物	7.53%	1.41%	5.8分
17	诺唯赞	7.38%	-0.21%	6.6分
18	东宝生物	6.64%	1.02%	6.3分
19	智飞生物	6.04%	-1.30%	5.8分
20	*ST四环	6.00%	5.58%	6.3分
21	康泰生物	5.45%	-1.20%	5.4分
22	艾迪药业	5.39%	2.63%	6.1分
23	赛伦生物	5.28%	-1.23%	5.4分
24	安科生物	5.17%	-5.88%	5.1分
25	百克生物	4.58%	-0.35%	6.2分
26	成大生物	4.52%	1.05%	6.0分
27	辽宁成大	4.03%	-2.69%	5.4分
28	通化东宝	3.80%	-2.28%	5.4分
29	卫光生物	3.51%	-0.14%	6.2分
30	义翘神州	3.50%	-0.51%	5.0分
31	百普赛斯	3.09%	-1.96%	4.7分
32	博雅生物	2.33%	-1.81%	5.6分
33	上海莱士	2.25%	-1.30%	6.4分
34	诺诚健华	2.23%	1.23%	6.3分
35	华兰生物	2.05%	-2.38%	6.3分
36	凯因科技	0.91%	-0.96%	5.2分
37	派林生物	0.31%	0.56%	6.6分
38	我武生物	-0.21%	1.83%	5.1分
39	康希诺	-0.41%	-3.67%	5.1分
40	智翔金泰	-0.48%	-1.06%	4.9分
41	君实生物	-1.55%	-0.83%	5.3分
42	迈威生物	-2.06%	1.67%	5.1分
43	特宝生物	-2.13%	-0.28%	6.9分
44	百奥泰	-2.28%	0.15%	5.5分
45	欧林生物	-3.34%	-2.15%	5.8分
46	天坛生物	-3.47%	-1.50%	5.3分
47	西藏药业	-4.03%	1.03%	6.6分
48	神州细胞	-5.14%	-1.56%	5.5分
49	荣昌生物	-5.37%	1.34%	6.0分
50	甘李药业	-5.63%	1.63%	5.2分
51	康弘药业	-7.28%	-0.06%	5.5分
52	科兴制药	-7.46%	-6.11%	5.7分
53	康辰药业	-11.43%	-2.20%	5.5分
54	长春高新	-15.65%	-2.76%	5.0分
55	禾元生物	-	-11.03%	4.0分

<上一页 1 2 3 4 5...10 下一页>

行业评级

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：6.7基本面打败了80%的股票连续3年业绩增长30%的公司

该公司运营状况良好，多数机构认为该股长期投资价值较高。

个股深一度

潜在高分红能力：弱（45分）

基本面得分最高的股票

[ 截止日期：2025-09-30 ]公司经营

盈利能力：很强，居行业前列，两项指标的行业排名分别为 8/72 ， 23/72。

[{"date":"2025-09-30","value":"7.33","vol":"-9.78"},{"date":"2025-06-30","value":"5.48","vol":"-0.61"},{"date":"2025-03-31","value":"2.79","vol":"0.46"},{"date":"2024-12-31","value":"5.64","vol":"-0.68"},{"date":"2024-09-30","value":"4.62","vol":"1.34"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净资产收益率(%)	7.33	5.48	2.79	5.64	4.62
行业(%)	-9.78	-0.61	0.46	-0.68	1.34

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"76.18","vol":"67.61"},{"date":"2025-06-30","value":"76.25","vol":"68.28"},{"date":"2025-03-31","value":"76.76","vol":"68.43"},{"date":"2024-12-31","value":"74.83","vol":"69.85"},{"date":"2024-09-30","value":"75.36","vol":"70.47"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
销售毛利率(%)	76.18	76.25	76.76	74.83	75.36
行业(%)	67.61	68.28	68.43	69.85	70.47

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：较强，高于行业平均，两项指标的行业排名分别为 10/72 ， 11/72。

[{"date":"2025-09-30","value":"35.73","vol":"45.25"},{"date":"2025-06-30","value":"57.18","vol":"6902.04"},{"date":"2025-03-31","value":"75.76","vol":"6125.27"},{"date":"2024-12-31","value":"16.77","vol":"47.35"},{"date":"2024-09-30","value":"17.81","vol":"175.00"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
营业收入同比增长率(%)	35.73	57.18	75.76	16.77	17.81
行业(%)	45.25	6902.04	6125.27	47.35	175.00

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"61.32","vol":"44.80"},{"date":"2025-06-30","value":"101.96","vol":"5.44"},{"date":"2025-03-31","value":"224.90","vol":"-8.46"},{"date":"2024-12-31","value":"80.75","vol":"-9.81"},{"date":"2024-09-30","value":"90.36","vol":"-52.40"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净利润同比增长率(%)	61.32	101.96	224.90	80.75	90.36
行业(%)	44.80	5.44	-8.46	-9.81	-52.40

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：尚可，接近行业平均，两项指标的行业排名分别为 18/72 ， 26/72。

[{"date":"2025-09-30","value":"0.25","vol":"0.22"},{"date":"2025-06-30","value":"0.17","vol":"0.14"},{"date":"2025-03-31","value":"0.08","vol":"0.06"},{"date":"2024-12-31","value":"0.26","vol":"0.29"},{"date":"2024-09-30","value":"0.19","vol":"0.22"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
总资产周转率(次)	0.25	0.17	0.08	0.26	0.19
行业(次)	0.22	0.14	0.06	0.29	0.22

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.67","vol":"0.92"},{"date":"2025-06-30","value":"0.45","vol":"0.56"},{"date":"2025-03-31","value":"0.21","vol":"0.26"},{"date":"2024-12-31","value":"0.80","vol":"1.17"},{"date":"2024-09-30","value":"0.59","vol":"0.86"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
存货增长率(次)	0.67	0.45	0.21	0.80	0.59
行业(次)	0.92	0.56	0.26	1.17	0.86

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2025-09-30","value":"23.81","vol":"1.84"},{"date":"2025-06-30","value":"8.30","vol":"-1377.61"},{"date":"2025-03-31","value":"16.12","vol":"-46.99"},{"date":"2024-12-31","value":"8.99","vol":"-11.33"},{"date":"2024-09-30","value":"42.91","vol":"-30.88"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
现金流量净额/营业收入	23.81	8.30	16.12	8.99	42.91
行业	1.84	-1377.61	-46.99	-11.33	-30.88

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"2.56","vol":"1.59"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.70","vol":"2.01"},{"date":"2024-09-30","value":"","vol":"0.00"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资本支出／折旧和摊销	-	2.56	-	1.70	-
行业	0.00	1.59	0.00	2.01	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：尚可，接近行业平均，两项指标的行业排名分别为 41/72 ， 39/72。

[{"date":"2025-09-30","value":"7.20","vol":"6.00"},{"date":"2025-06-30","value":"5.40","vol":"6.64"},{"date":"2025-03-31","value":"4.92","vol":"7.75"},{"date":"2024-12-31","value":"4.73","vol":"6.72"},{"date":"2024-09-30","value":"8.04","vol":"7.02"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
流动比率	7.20	5.40	4.92	4.73	8.04
行业	6.00	6.64	7.75	6.72	7.02

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"5.39","vol":"4.84"},{"date":"2025-06-30","value":"3.74","vol":"5.30"},{"date":"2025-03-31","value":"3.40","vol":"6.35"},{"date":"2024-12-31","value":"3.31","vol":"5.40"},{"date":"2024-09-30","value":"6.62","vol":"5.66"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
速动比率	5.39	3.74	3.40	3.31	6.62
行业	4.84	5.30	6.35	5.40	5.66

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：较强，高于行业平均，两项指标的行业排名分别为 45/72 ， 45/72。

[{"date":"2025-09-30","value":"7.09","vol":"28.18"},{"date":"2025-06-30","value":"7.68","vol":"26.73"},{"date":"2025-03-31","value":"7.92","vol":"26.03"},{"date":"2024-12-31","value":"8.21","vol":"25.81"},{"date":"2024-09-30","value":"8.30","vol":"24.44"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资产负债率(%)	7.09	7.68	7.92	8.21	8.30
行业(%)	28.18	26.73	26.03	25.81	24.44

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.08","vol":"0.58"},{"date":"2025-06-30","value":"0.08","vol":"1.11"},{"date":"2025-03-31","value":"0.09","vol":"0.78"},{"date":"2024-12-31","value":"0.09","vol":"0.87"},{"date":"2024-09-30","value":"0.09","vol":"0.40"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
产权比率 (%)	0.08	0.08	0.09	0.09	0.09
行业(%)	0.58	1.11	0.78	0.87	0.40

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。

研究机构	评级日期	最新评级	上次评级
东方证券	2025-11-05	买入
国投证券	2025-10-31	买入	买入
国金证券	2025-10-30	买入
太平洋	2025-09-11	买入
中信证券	2025-08-20	买入
国泰海通证券	2025-08-17	买入

机构预测

机构预测该股2025年每股收益与前一年相同，长期投资价值一般。

[{"date":"2021","yellowRectValue":"14.53","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"-4.40","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"3.40","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"6.15","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"11.38","blueLineValue":"1.90","type":"YC"}]

[甘李药业]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]